UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Metal recovery from incineration bottom ash: State-of-the-art and recent developments

Journal of hazardous materials, 2020-07, Vol.393, p.122433-122433, Article 122433

2020

Volltextzugriff (PDF)

Challenges in the management of advanced, ER-positive, HER2-negative breast cancer

Nature reviews. Clinical oncology, 2015-09, Vol.12 (9), p.541-552

2015

Volltextzugriff (PDF)

Continued value of adjuvant anthracyclines as treatment for early breast cancer

The lancet oncology, 2015-07, Vol.16 (7), p.e362-e369

2015

Volltextzugriff (PDF)

Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)

The lancet oncology, 2012-04, Vol.13 (4), p.e148-e160

2012

Volltextzugriff (PDF)

Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer

International journal of molecular sciences, 2021-04, Vol.22 (9), p.4687

2021

Volltextzugriff (PDF)

Serum Metabolomic Profiles Identify ER-Positive Early Breast Cancer Patients at Increased Risk of Disease Recurrence in a Multicenter Population

Clinical cancer research, 2017-03, Vol.23 (6), p.1422-1431

2017

Volltextzugriff (PDF)

Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology

The lancet oncology, 2007-12, Vol.8 (12), p.1101-1115

2007

Volltextzugriff (PDF)

Clinical trials in older patients with cancer - typical challenges, possible solutions, and a paradigm of study design in breast cancer

Acta oncologica, 2024-06, Vol.63 (1), p.441

2024

Volltextzugriff (PDF)

A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)

Breast cancer research and treatment, 2021-11, Vol.190 (2), p.265-275

2021

Volltextzugriff (PDF)

Life Cycle Assessment of Reusable Plastic Crates (RPCs)

Resources (Basel), 2019-06, Vol.8 (2), p.110

2019

Volltextzugriff (PDF)

PIK3CA co-occurring mutations and copy-number gain in hormone receptor positive and HER2 negative breast cancer

NPJ breast cancer, 2022-02, Vol.8 (1), p.24-24, Article 24

2022

Volltextzugriff (PDF)

Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients

Breast cancer research and treatment, 2009-12, Vol.118 (3), p.523-530

2009

Volltextzugriff (PDF)

Metabolomics: Available Results, Current Research Projects in Breast Cancer, and Future Applications

Journal of clinical oncology, 2007-07, Vol.25 (19), p.2840-2846

2007

Volltextzugriff (PDF)

Evaluation of Tumor Response, Disease Control, Progression-Free Survival, and Time to Progression As Potential Surrogate End Points in Metastatic Breast Cancer

Journal of clinical oncology, 2008-04, Vol.26 (12), p.1987-1992

2008

Volltextzugriff (PDF)

IN31 - MANAGEMENT OF ABC: LESSONS LEARNED FROM COVID-19

Breast (Edinburgh), 2021-10, Vol.59, p.S35-S35

Biganzoli, Laura

2021

Volltextzugriff (PDF)

MANAGEMENT OF ABC: LESSONS LEARNED FROM COVID-19

Breast (Edinburgh), 2021-10, Vol.59, p.S35-S35

Biganzoli, Laura

2021

Volltextzugriff (PDF)

Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial

Breast cancer research : BCR, 2021-03, Vol.23 (1), p.38-38, Article 38

2021

Volltextzugriff (PDF)

Cell-Free DNA-Methylation-Based Methods and Applications in Oncology

Biomolecules (Basel, Switzerland), 2020-12, Vol.10 (12), p.1677

2020

Volltextzugriff (PDF)

Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study

Breast (Edinburgh), 2024-10, Vol.77, p.103769, Article 103769

2024

Volltextzugriff (PDF)

PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology

Breast (Edinburgh), 2022-12, Vol.66, p.293-304

2022

Volltextzugriff (PDF)

A multi-stakeholder approach in optimising patients’ needs in the benefit assessment process of new metastatic breast cancer treatments

Breast (Edinburgh), 2020-08, Vol.52, p.78-87

2020

Volltextzugriff (PDF)

Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial

Breast cancer research : BCR, 2019-05, Vol.21 (1), p.71-71, Article 71

2019

Volltextzugriff (PDF)

EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancer

Breast cancer research : BCR, 2020-08, Vol.22 (1), p.83-11, Article 83

2020

Volltextzugriff (PDF)

Intermediate Bulk Containers Re-use in the Circular Economy: An LCA Evaluation

Procedia CIRP, 2018, Vol.69, p.827-832

2018

Volltextzugriff (PDF)

Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer

Journal of clinical oncology, 2008-04, Vol.26 (12), p.1980-1986

2008

Volltextzugriff (PDF)

1 – 25 von 242

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(229)
Mit Volltextzugriff
(220)

Publikationsform

Sprache

Englisch
(242)

Erscheinungsjahr

n.n

Thema

Science & Technology
(157)
Life Sciences & Biomedicine
(153)
Oncology
(122)
Humans
(100)
Female
(86)
Breast Cancer
(79)
Breast Neoplasms - Drug Therapy
(55)
Aged
(51)
Chemotherapy
(44)
Breast Neoplasms - Pathology
(38)
Middle Aged
(38)
Tumors
(32)
Adult
(31)
Patients
(28)
Hematology, Oncology And Palliative Medicine
(27)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(26)
Biological And Medical Sciences
(26)
Medical Sciences
(26)
Treatment Outcome
(26)
Cancer Therapies
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Metal recovery from incineration bottom ash: State-of-the-art and recent developments

Challenges in the management of advanced, ER-positive, HER2-negative breast cancer

Continued value of adjuvant anthracyclines as treatment for early breast cancer

Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)

Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer

Serum Metabolomic Profiles Identify ER-Positive Early Breast Cancer Patients at Increased Risk of Disease Recurrence in a Multicenter Population

Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology

Clinical trials in older patients with cancer - typical challenges, possible solutions, and a paradigm of study design in breast cancer

A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)

Life Cycle Assessment of Reusable Plastic Crates (RPCs)

PIK3CA co-occurring mutations and copy-number gain in hormone receptor positive and HER2 negative breast cancer

Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients

Metabolomics: Available Results, Current Research Projects in Breast Cancer, and Future Applications

Evaluation of Tumor Response, Disease Control, Progression-Free Survival, and Time to Progression As Potential Surrogate End Points in Metastatic Breast Cancer

IN31 - MANAGEMENT OF ABC: LESSONS LEARNED FROM COVID-19

MANAGEMENT OF ABC: LESSONS LEARNED FROM COVID-19

Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial

Cell-Free DNA-Methylation-Based Methods and Applications in Oncology

Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study

PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology

A multi-stakeholder approach in optimising patients’ needs in the benefit assessment process of new metastatic breast cancer treatments

Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial

EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancer

Intermediate Bulk Containers Re-use in the Circular Economy: An LCA Evaluation

Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer

Suchergebnisse filtern